î
îŒ
î
180 Life Sciences Corp
ATNF7.040USD
0.000
çµå€Â 12/19, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
42.52Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± 180 Life Sciences Corp äŒæ¥å
180 Life Sciences Corp. is focused on developing new technologies across multiple sectors. The Company is focused on iGaming sector, through its iGaming Technology Platform. The Company also continues to evaluate monetization strategies for its biotechnology assets.
180 Life Sciences Corpã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãATNF
äŒç€Ÿå180 Life Sciences Corp
äžå Žæ¥Jun 07, 2017
æé«çµå¶è²¬ä»»è
ãCEOãMr. Blair Jordan
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jun 07
æ¬ç€Ÿæåšå°3000 El Camino Real
éœåžPALO ALTO
蚌åžååŒæNASDAQ Capital Market Consolidated
åœUnited States of America
éµäŸ¿çªå·94306
é»è©±çªå·16505070669
ãŠã§ããµã€ãhttps://180lifesciences.com/
äŒæ¥ã³ãŒãATNF
äžå Žæ¥Jun 07, 2017
æé«çµå¶è²¬ä»»è
ãCEOãMr. Blair Jordan
180 Life Sciences Corpã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
688.16K
+12058.30%
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
428.70K
-3.75%
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
324.87K
--
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. Jason G. New
Mr. Jason G. New
Director
Director
--
--
Ms. Crystal Heter
Ms. Crystal Heter
Independent Director
Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
688.16K
+12058.30%
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
428.70K
-3.75%
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
324.87K
--
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. Jason G. New
Mr. Jason G. New
Director
Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Thu, Dec 18
æŽæ°æå»: Thu, Dec 18
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Cyber Citadel
8.63%
Electric Capital Partners, LLC
7.98%
Pemble (Brian James)
7.74%
Zippy, Inc
7.74%
FF Consumer Growth II, LP
5.39%
ä»ã®
62.52%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Cyber Citadel
8.63%
Electric Capital Partners, LLC
7.98%
Pemble (Brian James)
7.74%
Zippy, Inc
7.74%
FF Consumer Growth II, LP
5.39%
ä»ã®
62.52%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
30.52%
Individual Investor
20.73%
Hedge Fund
11.14%
Investment Advisor
6.92%
Investment Advisor/Hedge Fund
2.51%
Venture Capital
1.28%
Research Firm
0.96%
Pension Fund
0.10%
ä»ã®
25.84%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Oct 1
æŽæ°æå»: Wed, Oct 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q3
49
2.39M
14.13%
+2.27M
2025Q2
52
4.40M
43.09%
+1.20M
2025Q1
53
1.98M
52.21%
+1.28M
2024Q4
50
767.05K
24.14%
+685.05K
2024Q3
50
163.68K
7.41%
+97.43K
2024Q2
54
35.70K
4.43%
-40.39K
2024Q1
61
51.17K
6.90%
-21.55K
2023Q4
66
65.60K
11.28%
+5.63K
2023Q3
73
63.54K
20.50%
+26.66K
2023Q2
76
29.62K
13.63%
-18.64K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
FF Consumer Growth II, LP
11.59M
7.24%
+11.59M
--
Aug 04, 2025
Citadel Advisors LLC
8.42M
5.26%
+8.42M
--
Sep 25, 2025
Steadfast Capital Management LP
11.32M
7.07%
+11.32M
--
Aug 04, 2025
Rudisill (McAndrew)
6.33M
3.95%
+6.33M
--
Aug 20, 2025
Smith (Ryan Lewis)
167.18K
0.1%
--
--
Aug 20, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Schwab U.S. Small-Cap ETF
0.01%
Schwab U.S. Broad Market ETF
0%
Schwab U.S. Small-Cap ETF
æ¯ç0.01%
Schwab U.S. Broad Market ETF
æ¯ç0%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
Feb 26, 2024
Merger
19â1
Feb 26, 2024
Merger
19â1
Feb 26, 2024
Merger
19â1
Feb 26, 2024
Merger
19â1
Dec 16, 2022
Merger
20â1
Dec 16, 2022
Merger
20â1
æ¥ä»
çš®é¡
æ¯ç
Feb 26, 2024
Merger
19â1
Feb 26, 2024
Merger
19â1
Feb 26, 2024
Merger
19â1
Feb 26, 2024
Merger
19â1
Dec 16, 2022
Merger
20â1
Dec 16, 2022
Merger
20â1
Dec 16, 2022
Merger
20â1
Dec 16, 2022
Merger
20â1
ãããã質å
180 Life Sciences Corpã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
î180 Life Sciences Corpã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
FF Consumer Growth II, LPã¯11.59Mæ ªãä¿æããŠãããããã¯å šäœã®7.24%ã«çžåœããŸãã
Citadel Advisors LLCã¯8.42Mæ ªãä¿æããŠãããããã¯å šäœã®5.26%ã«çžåœããŸãã
Steadfast Capital Management LPã¯11.32Mæ ªãä¿æããŠãããããã¯å šäœã®7.07%ã«çžåœããŸãã
Rudisill (McAndrew)ã¯6.33Mæ ªãä¿æããŠãããããã¯å šäœã®3.95%ã«çžåœããŸãã
Smith (Ryan Lewis)ã¯167.18Kæ ªãä¿æããŠãããããã¯å šäœã®0.10%ã«çžåœããŸãã
FF Consumer Growth II, LPã¯11.59Mæ ªãä¿æããŠãããããã¯å šäœã®7.24%ã«çžåœããŸãã
Citadel Advisors LLCã¯8.42Mæ ªãä¿æããŠãããããã¯å šäœã®5.26%ã«çžåœããŸãã
Steadfast Capital Management LPã¯11.32Mæ ªãä¿æããŠãããããã¯å šäœã®7.07%ã«çžåœããŸãã
Rudisill (McAndrew)ã¯6.33Mæ ªãä¿æããŠãããããã¯å šäœã®3.95%ã«çžåœããŸãã
Smith (Ryan Lewis)ã¯167.18Kæ ªãä¿æããŠãããããã¯å šäœã®0.10%ã«çžåœããŸãã
180 Life Sciences Corpã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
î180 Life Sciences Corpã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
Cyber Citadel
Electric Capital Partners, LLC
Pemble (Brian James)
Cyber Citadel
Electric Capital Partners, LLC
Pemble (Brian James)
180 Life Sciences CorpïŒATNFïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2025Q3æç¹ã§ã180 Life Sciences Corpã®æ ªåŒãä¿æããŠããæ©é¢ã¯49瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ2.39Mã§ãå
šäœã®14.13%ãå ããŠããŸãã2025Q2ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-28.96%å¢å ããŠããŸãã
180 Life Sciences Corpã®æ倧ã®åçæºã¯äœã§ããïŒ
î--ã«ãããŠã--éšéã180 Life Sciences Corpã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
